Manchester BIOGEL Company
Manchester BIOGEL is a developer of peptide-based hydrogels technology intended to improve cell culture. The company's technology offers a family of high-quality peptide hydrogels, with a range of mechanical and functional properties to open up exciting new opportunities within the fields of 3D cell culture, 3D bioprinting, regenerative medicine, and medical devices, enabling doctors to solve current healthcare challenges and find the suitable materials for their application needs.
Total Funding:
£197 075
Headquarters:
Alderley, United Kingdom
Funding Status:
Private
Employee Number:
1-10
Estimated Revenue:
£779 800
Last Funding Type:
Generating Revenue
Last Funding Date:
04-05-2019
Investors Number:
4
Founded Date:
2016
Industry:
BioTech